{"database": "lobbying", "table": "lobbying_activities", "rows": [[1916673, "c28f2f31-f87f-4a40-abb8-e7abaceb9e42", "Q4", "NATIONAL COMMUNITY PHARMACISTS ASSOCIATION", 27478, "NATIONAL COMMUNITY PHARMACISTS ASSOCIATION", 2016, "fourth_quarter", "PHA", "H.R. 244 - MAC Transparency Act of 2015; \nCongressional Oversight of 340 B Program;\nS. 1406 - Saving Access to Compounding Medications for Special Needs Patients Act;\nIssues related to FDA implementation of The Drug Quality and Security Act related to compounding;\nIssues Related to Direct and Indirect Renumeration (DIR) Fees;", "Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Office of Natl Drug Control Policy (NDCP),Office of Personnel Management (OPM),SENATE", null, 245000, 0, 0, "2017-01-18T08:03:41-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1916673"], "units": {}, "query_ms": 4.05681598931551, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}